Covered recipient · General Payments record
MARK CHIH KUANG CHIEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,531.17
- Reported across 132 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $431.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $76.90 | 3 |
| Lilly USA, LLC | $65.99 | 3 |
| Amneal Pharmaceuticals LLC | $48.54 | 2 |
| Merck Sharp & Dohme Corporation | $44.71 | 2 |
| Cleerly, Inc. | $44.54 | 1 |
| Novo Nordisk AS | $44.16 | 2 |
| ABBVIE INC. | $37.49 | 2 |
| Exact Sciences Corporation | $27.95 | 1 |
| Astellas Pharma US Inc | $21.11 | 1 |
| Janssen Pharmaceuticals, Inc | $20.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.37 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103459666 | CMS |
| ABBVIE INC. | $15.12 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103459668 | CMS |
| Amneal Pharmaceuticals LLC | $24.43 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139182662 | CMS |
| Amneal Pharmaceuticals LLC | $24.11 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139182664 | CMS |
| Astellas Pharma US Inc | $21.11 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426566 | CMS |
| Cleerly, Inc. | $44.54 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144711230 | CMS |
| Exact Sciences Corporation | $27.95 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114614375 | CMS |
| Janssen Pharmaceuticals, Inc | $20.21 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078004086 | CMS |
| Lilly USA, LLC | $24.50 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135168286 | CMS |
| Lilly USA, LLC | $16.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135162419 | CMS |
| Lilly USA, LLC | $24.95 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135152320 | CMS |
| Merck Sharp & Dohme LLC | $23.80 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141860922 | CMS |
| Merck Sharp & Dohme LLC | $20.91 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141669174 | CMS |
| Novo Nordisk Inc | $20.01 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907547 | CMS |
| Novo Nordisk Inc | $24.15 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097054927 | CMS |
| PFIZER INC. | $23.53 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131947784 | CMS |
| PFIZER INC. | $26.56 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131939087 | CMS |
| PFIZER INC. | $26.81 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131984363 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.